LGND Deferred Revenue
Ligand Pharmaceuticals Inc · Deferred Revenue

LGND Deferred Revenue
Latest reported$621.00Kperiod ending
LGND FY Deferred Revenue ($0.00 → $621.00K)
Annual deferred revenue
High-resolution chart · PNG
LGND deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 621,000 | |
| 1,899,000 | |
| 1,843,000 | |
| 976,000 | |
| 654,000 | |
| 29,435,000 | |
| 2,139,000 | |
| 3,286,000 | |
| 173,000 | |
| 0 | |
| -934,000 | |
| 150,000 | |
| 116,000 | |
| 486,000 | |
| 1,240,000 | |
| 1,702,000 | |
| 6,691,000 | |
| 12,265,000 | |
| 1,964,000 | |
| 59,945,000 | |
| 157,519,000 | |
| 152,528,000 | |
| 2,564,000 | |
| 4,683,000 | |
| 8,729,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |